This Week in Startups: The 5 Stories That Actually Matter
From a VC firm's $14 billion bet paying off to a cyber warfare unicorn born in under two years, here's what actually moved this week.
1. Menlo Ventures Just Cashed In a $500M Bet Nobody Else Wanted to Make
Menlo Ventures raised $3 billion in new capital, the largest fundraise in the firm’s 50-year history, after its early investment in Anthropic, now worth nearly $14 billion as Anthropic’s valuation climbed past $900 billion. Menlo led Anthropic’s Series D in 2024 by structuring roughly $500 million of that round as a special purpose vehicle, at a time when no major firm was writing three-quarter-billion-dollar checks. AI Funding TrackerTech Funding News
Spence’s take: Everyone calls these bets “contrarian” after they pay off. The actual contrarian move happened in 2024, when nobody knew if it would work.
2. XCures Doubled Its Valuation Cleaning Up Medical Records With AI
XCures landed a $46 million Series B led by Innovius Capital, bringing total funding to more than $76 million and valuing the company at $127 million post-money, more than double its prior round. The company grew from roughly $3 million to $10 million in annualized recurring revenue in 2025 and is on track to break $20 million in 2026, while achieving cash-flow breakeven last year. Calcali Tech
Spence’s take: A profitable company intentionally entering a burn phase to grow faster is one of the most underrated signals in venture. It means the founders chose growth, not the other way around.
3. Healthcare AI Just Crossed an $8.5 Billion Threshold This Year Alone
Investors have put an estimated $8.5 billion into seed- to growth-stage funding for AI-powered health tech companies in 2026 as of late June. Calcali Tech
Spence’s take: Healthcare moves slower than every other sector until it doesn’t. This number says we’re past the “if” stage and into the “how fast” stage.
4. Twenty’s $1B Cyber Warfare Bet Is Still the Story Nobody’s Fully Priced In
Twenty, the Arlington-based offensive cyber startup for the U.S. military, became America’s first venture-backed cyber warfare unicorn earlier this month after raising a $100 million Series B at a $1 billion valuation, less than two years after founding.
Spence’s take: A billion-dollar valuation with no disclosed revenue isn’t proof of a great company. It’s proof that investors believe the category just became fundable. Those are very different things.
5. Menlo’s Anthology Fund Shows the New VC Playbook: Be the Insider, Not Just the Investor
Menlo launched a $100 million fund called Anthology in partnership with Anthropic, which has since grown to roughly $250 million deployed, backed more than 60 companies, and produced exits including Graphite (acquired by Cursor) and Astrix Security (acquired by Cisco). Tech Funding News
Spence’s take: The smartest funds aren’t just writing checks anymore. They’re building proprietary pipelines into the company they bet the firm on. That’s a moat most LPs don’t fully appreciate yet.
Why Menlo Is the One to Watch
I want to run this through asymmetric bets, a model I cover in my book, Mental Models: How to Think, Act, and Win. Menlo’s 2024 Anthropic investment had a defined downside: the capital they put in. The upside, if Anthropic became one of the most valuable private companies in the world, was essentially unbounded. That’s the entire logic of venture capital distilled into one decision. Most investors talk about asymmetric bets. Menlo actually structured a $500 million SPV around one, at a moment when the broader market had gone quiet on big checks. The lesson isn’t “go invest in AI labs.” It’s that real conviction shows up as structuring your bet correctly when consensus is against you, not just picking the right company.
——————————————————————————————————————
If this was useful, share it with someone who builds things. And if you want the full toolkit of 50 mental models, you can grab my book, Mental Models: How to Think, Act, and Win, right now.
——————————————————————————————————————
Next week’s deep-dive:
Next week, I'm picking one company from this list and going deep: total funding, market size, business model, the bull case, and what could go wrong. Subscribe so you don't miss it.
——————————————————————————————————————